anti-HBV therapy (Tripep)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameanti-HBV therapy (Tripep)
Drug Alias Namehepatitis B virus infection therapy (Tripep)
ClassificationBiologics > Protein drugs > Immunoglobulin > AntibodyBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesChrontech Pharma Ab
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesChrontech Pharma Ab
Active IndicationsN/A
Inactive IndicationsHepatitis B

Other Information

ATC CodeN/A
Related LinksN/A